inTEST Co. (NYSE:INTT - Free Report) - Northland Capmk dropped their Q2 2025 EPS estimates for shares of inTEST in a report released on Monday, May 5th. Northland Capmk analyst E. Jackson now expects that the company will post earnings of ($0.04) per share for the quarter, down from their prior forecast of $0.09. Northland Capmk has a "Hold" rating on the stock. The consensus estimate for inTEST's current full-year earnings is $0.41 per share. Northland Capmk also issued estimates for inTEST's Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.08 EPS, FY2025 earnings at ($0.09) EPS, Q1 2026 earnings at ($0.08) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at $0.01 EPS, Q4 2026 earnings at $0.10 EPS, FY2026 earnings at $0.02 EPS, FY2027 earnings at $0.17 EPS and FY2028 earnings at $0.28 EPS.
Separately, Lake Street Capital lowered their price objective on inTEST from $10.00 to $8.00 and set a "buy" rating on the stock in a report on Monday, May 5th.
Check Out Our Latest Report on inTEST
inTEST Stock Down 4.8 %
INTT traded down $0.31 during trading on Thursday, reaching $6.10. 11,622 shares of the stock traded hands, compared to its average volume of 67,101. The stock has a market cap of $76.22 million, a price-to-earnings ratio of 26.52 and a beta of 1.63. The stock's 50-day simple moving average is $6.66 and its two-hundred day simple moving average is $7.64. inTEST has a fifty-two week low of $5.24 and a fifty-two week high of $11.92. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.26 and a quick ratio of 1.38.
inTEST (NYSE:INTT - Get Free Report) last issued its earnings results on Friday, May 2nd. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). inTEST had a return on equity of 5.31% and a net margin of 2.33%. During the same quarter in the prior year, the firm earned $0.10 EPS.
Insider Transactions at inTEST
In related news, Director Gerald J. Maginnis acquired 7,557 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was acquired at an average price of $5.78 per share, for a total transaction of $43,679.46. Following the completion of the acquisition, the director now owns 78,057 shares of the company's stock, valued at $451,169.46. This trade represents a 10.72 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 5.50% of the stock is owned by company insiders.
Institutional Trading of inTEST
Several hedge funds have recently added to or reduced their stakes in the business. Byrne Asset Management LLC bought a new position in shares of inTEST in the 1st quarter valued at about $27,000. Farther Finance Advisors LLC bought a new stake in inTEST in the 1st quarter valued at $41,000. Jane Street Group LLC increased its holdings in shares of inTEST by 9.0% in the fourth quarter. Jane Street Group LLC now owns 31,644 shares of the company's stock valued at $272,000 after purchasing an additional 2,602 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of inTEST by 42.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company's stock worth $274,000 after buying an additional 11,102 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in inTEST by 8.2% in the 4th quarter. Northern Trust Corp now owns 40,328 shares of the company's stock valued at $346,000 after acquiring an additional 3,048 shares during the period. Institutional investors and hedge funds own 63.18% of the company's stock.
inTEST Company Profile
(
Get Free Report)
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
See Also

Before you consider inTEST, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.
While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.